美邦股份:连续3个交易日收盘价格涨幅偏离值累计超20%

Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from February 10 to February 12, 2026 [1] Group 1 - The company confirmed that its production and operations are normal, and there are no significant changes in the external environment [1] - There are no undisclosed significant information apart from what has already been disclosed [1] - No media reports or market rumors have been found that could significantly impact the stock price, and the company is not involved in any market hot concepts [1] Group 2 - During the period of stock price fluctuation, the company's directors, senior executives, controlling shareholders, and actual controllers did not engage in any buying or selling of the company's stock [1] - The company reminds investors to pay attention to trading risks and to invest rationally [1]

Shaanxi Meibang Pharmaceutical -美邦股份:连续3个交易日收盘价格涨幅偏离值累计超20% - Reportify